DC Field | Value | Language |
---|---|---|
dc.contributor.author | D H Nam | - |
dc.contributor.author | Jung Hun Koh | - |
dc.contributor.author | S Y Lee | - |
dc.date.accessioned | 2017-04-19T08:55:55Z | - |
dc.date.available | 2017-04-19T08:55:55Z | - |
dc.date.issued | 1993 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/4661 | - |
dc.description.abstract | In order to prepare a novel human insulin analogue substituted with homoserine at B30 position, (B30-homoserine) human insulin, a synthetic gene was designed by linking directly a gene for B chain with that for A chain. This gene was constructed by enzymatic joining of 10 different synthetic oligonucleotides, and then inserted at the polylinker region of pUC19 plasmid. To achieve a high level of gene expression, the gene fusion technique was employed using amino terminal regions of lacZ gene up to ClaI or Hpal, and either of them has been located under tac promoter. The chemical induction of these fused genes by isopropyl-β-D-thiogalactopyranoside (IPTG) gave a satisfactory level of expression in Escherichia coli harboring the constructed plasmids. It was observed that the fused gene product as a single chain insulin precursor was produced more than 30% of total cell protein of E. coli as a form of inclusion body. | - |
dc.publisher | Pharmaceutical Soc Korea | - |
dc.title | Design and cloning of the gene for a novel insulin analogue,(B30-homoserine) human insulin | - |
dc.title.alternative | Design and cloning of the gene for a novel insulin analogue,(B30-homoserine) human insulin | - |
dc.type | Article | - |
dc.citation.title | Archives of Pharmacal Research | - |
dc.citation.number | 4 | - |
dc.citation.endPage | 275 | - |
dc.citation.startPage | 271 | - |
dc.citation.volume | 16 | - |
dc.contributor.affiliatedAuthor | Jung Hun Koh | - |
dc.contributor.alternativeName | 남두 | - |
dc.contributor.alternativeName | 고정헌 | - |
dc.contributor.alternativeName | 이승엽 | - |
dc.identifier.bibliographicCitation | Archives of Pharmacal Research, vol. 16, no. 4, pp. 271-275 | - |
dc.identifier.doi | 10.1007/BF02977515 | - |
dc.subject.keyword | recombinant human insulin | - |
dc.subject.keyword | insulin analogue | - |
dc.subject.keyword | insulin [b30 homoserine] | - |
dc.subject.keyword | single chain insulin precursor | - |
dc.subject.keyword | gene fusion | - |
dc.subject.local | recombinant human insulin | - |
dc.subject.local | insulin analogue | - |
dc.subject.local | Insulin analogue | - |
dc.subject.local | insulin [b30 homoserine] | - |
dc.subject.local | single chain insulin precursor | - |
dc.subject.local | Single chain insulin precursor | - |
dc.subject.local | gene fusion | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.